RSLS [NASD]
ReShape Lifesciences Inc.
Index- P/E- EPS (ttm)-4.54 Insider Own6.20% Shs Outstand19.00M Perf Week-13.91%
Market Cap13.49M Forward P/E- EPS next Y-1.16 Insider Trans-6.53% Shs Float16.33M Perf Month-18.40%
Income-61.90M PEG- EPS next Q-0.17 Inst Own18.10% Short Float1.16% Perf Quarter-33.02%
Sales13.60M P/S0.99 EPS this Y-4.60% Inst Trans2.05% Short Ratio1.22 Perf Half Y-64.68%
Book/sh2.58 P/B0.28 EPS next Y60.50% ROA-87.80% Target Price4.75 Perf Year-92.78%
Cash/sh1.20 P/C0.59 EPS next 5Y- ROE-128.00% 52W Range0.65 - 14.40 Perf YTD-56.71%
Dividend- P/FCF- EPS past 5Y32.80% ROI-126.80% 52W High-95.07% Beta-0.59
Dividend %- Quick Ratio3.70 Sales past 5Y32.00% Gross Margin61.40% 52W Low8.90% ATR0.07
Employees47 Current Ratio4.10 Sales Q/Q-2.00% Oper. Margin- RSI (14)34.41 Volatility7.11% 9.61%
OptionableNo Debt/Eq0.00 EPS Q/Q-287.80% Profit Margin- Rel Volume0.39 Prev Close0.77
ShortableYes LT Debt/Eq0.00 EarningsMay 23 BMO Payout- Avg Volume155.99K Price0.71
Recom2.00 SMA20-10.32% SMA50-29.34% SMA200-62.36% Volume61,400 Change-7.85%
May-23-22 08:00AM  
May-19-22 08:30AM  
May-16-22 08:30AM  
Apr-26-22 08:30AM  
Mar-31-22 11:33AM  
Mar-28-22 04:05PM  
Mar-24-22 08:30AM  
Mar-17-22 09:07AM  
Mar-09-22 08:30AM  
Jan-18-22 08:30AM  
Jan-13-22 08:30AM  
Dec-20-21 08:35AM  
08:35AM  
Dec-14-21 08:35AM  
Dec-09-21 12:19PM  
08:35AM  
Nov-16-21 08:30AM  
Nov-11-21 08:30AM  
Nov-08-21 08:30AM  
Nov-04-21 08:30AM  
Oct-19-21 08:30AM  
Oct-12-21 08:00AM  
Sep-23-21 08:00AM  
Sep-13-21 08:00AM  
Sep-09-21 08:30AM  
Aug-31-21 08:00AM  
Aug-20-21 12:24PM  
Aug-16-21 08:00AM  
Aug-05-21 08:00AM  
Aug-03-21 08:00AM  
Jul-29-21 08:30AM  
Jul-13-21 08:30AM  
Jul-07-21 08:30AM  
Jul-01-21 08:30AM  
Jun-30-21 08:30AM  
Jun-29-21 09:27AM  
Jun-17-21 08:45AM  
Jun-16-21 07:30AM  
Jun-15-21 12:05PM  
Jun-08-21 07:30AM  
May-24-21 07:30AM  
May-21-21 07:30AM  
May-18-21 07:30AM  
May-17-21 04:05PM  
Mar-10-21 04:30PM  
Mar-08-21 07:00AM  
Jan-22-21 04:46PM  
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STANKOVICH THOMASChief Financial OfficerMay 05Sale0.774,5293,487345,627May 12 04:05 PM
Bandy Barton P.President and CEOMay 05Sale0.7711,4178,791807,523May 12 04:13 PM
STANKOVICH THOMASChief Financial OfficerApr 01Sale1.135,0385,693350,156Apr 08 04:27 PM
Bandy Barton P.President and CEOApr 01Sale1.1311,06312,501818,940Apr 08 04:12 PM
STANKOVICH THOMASCFOFeb 28Sale1.063,6583,877355,194Mar 02 04:15 PM
Bandy Barton P.President and CEOFeb 28Sale1.066,5386,930830,003Mar 02 04:08 PM
Bandy Barton P.President and CEOJan 31Sale1.228,32410,155836,541Feb 02 04:32 PM
STANKOVICH THOMASChief Financial OfficerJan 31Sale1.223,6844,494358,852Feb 02 04:22 PM
Bandy Barton P.President and CEOJan 04Sale1.797,15012,798844,865Jan 28 04:58 PM
STANKOVICH THOMASChief Financial OfficerJan 04Sale1.783,1715,644362,536Jan 28 04:46 PM
Bandy Barton P.President and CEODec 02Sale1.8313,42724,571852,015Dec 09 04:22 PM
STANKOVICH THOMASChief Financial OfficerDec 02Sale1.834,3047,863365,707Dec 09 04:17 PM
STANKOVICH THOMASChief Financial OfficerNov 18Buy2.0220,00040,400370,011Nov 18 04:32 PM
Bandy Barton P.President and CEONov 02Sale2.6913,50536,328865,442Nov 16 04:18 PM
STANKOVICH THOMASChief Financial OfficerNov 02Sale2.694,32011,621350,011Nov 16 04:14 PM
STANKOVICH THOMASChief Financial OfficerOct 01Sale2.763,66010,102354,331Oct 12 07:40 PM
Bandy Barton P.President and CEOOct 01Sale2.7712,56534,805878,947Oct 12 07:35 PM
GLADNEY DAN WDirectorSep 10Sale2.99200,000598,000283,922Sep 17 06:37 PM
Bandy Barton P.President and CEOSep 10Sale2.89294,494851,088891,512Sep 17 07:07 PM
STANKOVICH THOMASChief Financial OfficerSep 10Sale2.8948,366139,778357,991Sep 17 06:51 PM
STANKOVICH THOMASChief Financial OfficerAug 30Buy3.4315,00051,43532,613Aug 31 04:31 PM
STANKOVICH THOMASChief Financial OfficerAug 20Buy3.2215,00048,28517,613Aug 24 08:59 AM